Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - India
 More »

  • Parexel Acquires Heron Group in Up To $38M Deal
    Heron employs about 140 people and is headquartered in Luton, U.K., with additional offices in India, Sweden, and the U.S. "We are pleased to be able to expand the expertise of our ...
    5-1-2013
  • The Globalization of IVD Companies
    ... Opportunities Abound for Big and Small Companies in Emerging Markets The BRIC countries, or Brazil, Russia, India, and China, were the initially identified emerging markets, ...
    5-1-2013
  • GEN | Biolinks
    Alimera Sciences Alkermes All India Bitoech Association Allergan Allinky ... Products Biotage BioTalent Canada Bioteach East BioteCANADA Biotech Consortium India Ltd. ...
  • Goodwin, Coldstream Team Up to Tackle ADCs
    GBI, which is owned by India-based Wallace Pharmaceuticals, has established several manufacturing collaborations not only with biopharmas but with research institutions as well. In ...
    4-25-2013
  • FusionVax Snags Exclusive Rights to HPV Drug in Asia
    the rights to ADXS-HPV for the Asia territory, exclusive of India, for all indications. .../refractory cervical cancer (Phase II, India), locally advanced cervical cancer (Phase ...
    4-22-2013
  • Biosimilars: 10 Drugs to Watch
    ... Reddy's Laboratories: Cresp® launched 2010 in India as that country's only darbopoetin ... development Cipla: Launches biosimilar in India on April 17, at a price of Rs. 6,150 ...
    4-22-2013
  • Pfenex and Agila Biotech Target Biosimilars
    This will allow us to not only leverage time and cost advantage of developing products in India and Malaysia, but also serve as a gateway to a vast region in South Asia, South-East ...
    4-16-2013
  • Five Japanese Pharmas Join Drug-Development Fund
    the company's individual global-health efforts, which include establishing mobile healthcare field clinics service in India, Cameroon, and Tanzania, to developing countries. ...
    4-8-2013
  • Pall Prepares to Open U.K. Life Sciences Center
    the Westborough, MA, and Menlo Park, CA, as well as investments previously announced in China, Singapore, and India. "Portsmouth represents an important life sciences hub for Pall. ...
    4-4-2013
  • Advertorial: United States Pharmacopeial Convention
    ... With its headquarters in Rockville, MD, USP also has sites and offices in Hyderabad, India; Shanghai, China; São Paulo, Brazil; and Basel, Switzerland. USP-NF provides ...
    4-1-2013
  • Reality Hinders Pharma's Big Plans in Emerging Markets
    Emerging markets themselves will expand by 2018, the report added. In addition to the "BRIC" cluster (Brazil, Russia, India, and China), plus Mexico and Turkey, Booz identified a ...
    4-1-2013
  • BD Expands Into Prefilled Generic Injectables
    in India, where the company is building a $275 million plant as part of a company-wide increase in manufacturing capacity designed to produce more injectables. Also in India, ...
    3-27-2013
  • Mylan Eyes Injectables Dominance with $1.6B+ Agila Buy
    and India with Agila's global pipeline of approximately 350 filings pending approval, including 122 ANDAs pending FDA approval, and nine manufacturing sites-six in India, two in ...
    2-28-2013
  • Taconic to Market Yecuris' Humanized Animal Models
    Taconic, who has been in the mouse model business since 1952 , are also spreading transgenic mice throughout India through a distribution agreement made earlier this month with ...
    2-25-2013
  • AstraZeneca, Russian Institute in Cancer Collaboration
    ... billion. "The R&D eco-systems of Russia and other emerging economies such as China, Brazil, and India are becoming increasingly important sources of innovation in medical science. ...
    2-12-2013
  • More »

    Journal Articles

  • Effectiveness of a New Granular Formulation of Biolarvicide Bacillus...
    Satyanarayan Tiwari, Susanta K. Ghosh, Pradeep K. Mittal, Aditya P. Dash
    Vector-Borne and Zoonotic Diseases
    Against Larvae of Malaria Vectors in India Vector-Borne and Zoonotic Diseases ... Field trials were conducted in a rural area and in Bangalore city, Karnataka, South India. ...
  • A Haplotype at the UCP1 Gene Locus Contributes to Genetic Risk...
    Karani S. Vimaleswaran, Venkatesan Radha, Saurabh Ghosh, Partha P. Majumder, M.R.S. Rao, Viswanathan Mohan
    Metabolic Syndrome and Related Disorders
    and 990 normal glucose tolerant (NGT) subjects, were chosen from the Chennai Urban Rural Epidemiological Study (CURES), an ongoing population-based study in southern India. ...
  • The Metabolic Syndrome in South Asians: Epidemiology, Determinants...
    Anoop Misra, Lokesh Khurana
    Metabolic Syndrome and Related Disorders
    syndrome is rapidly increasing in India and other south Asian countries, leading ... urban adolescent schoolchildren in north India for prevention of obesity (the MARG ...
  • Telemedicine in India: An Introduction
    Ronald C Merrell
    Telemedicine and e-Health
    Telemedicine in India: An Introduction Telemedicine and e-Health In this special section on telemedicine in India, authorities from practice, theory, technology, engineering, ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll